Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Orlova, Rashida V.
Issue
Section
Title
File
Vol 24, No 1 (2022)
CLINICAL ONCOLOGY
Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study
(Rus)
(Eng)
Vol 24, No 4 (2022)
CLINICAL ONCOLOGY
Place of durvalumab in the treatment of biliary tract cancer: A review
(Rus)
Vol 24, No 4 (2022)
CLINICAL ONCOLOGY
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
(Rus)
Vol 25, No 3 (2023)
CLINICAL ONCOLOGY
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”
(Rus)
Vol 25, No 3 (2023)
CLINICAL ONCOLOGY
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study
(Rus)
Vol 26, No 1 (2024)
Articles
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP